Achieve Life Sciences announced that its stockholders have approved a proposal to amend the company's Certificate of Incorporation, doubling the number of authorized shares of common stock from 150 million to 300 million. The amendment was approved at the Annual Meeting of Stockholders on July 2, 2026, and officially filed with the State of Delaware on July 6, 2026.
Key Details
- Authorized Share Increase: The number of authorized shares of common stock, par value $0.001 per share, was increased from 150,000,000 to 300,000,000.
- Stockholder Approval: The measure was approved at the company's Annual Meeting held on July 2, 2026, with over 64.7 million votes in favor.
- Effective Date: The Certificate of Amendment was filed and became effective on July 6, 2026.